# FDA Inspection 666040 - Krzysztof W. Selmaj, M.D., Ph.D. - May 10, 2010

Source: https://www.keypedia.com/records/fda_inspections/krzysztof-w-selmaj-md-phd/e0fd6a7e-7bae-4410-b22f-522883a42f19
Source feed: FDA_Inspections

> FDA Inspection 666040 for Krzysztof W. Selmaj, M.D., Ph.D. on May 10, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 666040
- Company Name: Krzysztof W. Selmaj, M.D., Ph.D.
- Inspection Date: 2010-05-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 989560 - 2016-09-23](https://www.keypedia.com/records/fda_inspections/krzysztof-w-selmaj-md-phd/e97538d4-7309-4b83-8695-a60eb0867825)
- [FDA Inspection 946867 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/krzysztof-w-selmaj-md-phd/cbce42cd-d27c-4240-81f7-4768c4ceffbb)
- [FDA Inspection 850062 - 2013-09-26](https://www.keypedia.com/records/fda_inspections/krzysztof-w-selmaj-md-phd/40afa384-65db-4b1e-9c1e-fedc972a4d22)

Company: https://www.keypedia.com/companies/krzysztof-w-selmaj-md-phd/a4d0c383-c8f0-461e-b741-fbe7098ce400

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c